NDC 51672-2115-0 - Feverall Childrens
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2115
- Requested NDC
- 51672-2115-0
- Package NDCs from labels
- 51672-2115-0, 51672-2115-2, 51672-2115-4
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Cosette Pharmaceuticals NC Laboratories, LLC
- Effective date
- 2026-08-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Feverall ® Children's | Sun Pharmaceutical Industries, Inc. | Cosette Pharmaceuticals NC Laboratories, LLC | 2026-08-24 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2115-0 | Feverall Childrens | 1 in 1 BLISTER PACK | SUPPOSITORY | 1 | 7 | |
| 51672-2115-2 | Feverall Childrens | 6 in 1 CARTON | SUPPOSITORY | 6 | 7 | |
| 51672-2115-4 | Feverall Childrens | 50 in 1 CARTON | SUPPOSITORY | 50 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2115 | FEVERALL CHILDRENS (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 6 | Current NDC, Legacy NDC, 3 package rows | 20241211_861e2987-5473-45b0-b2a6-f980a9b0e809.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2115-2 | EA - Each | 51672-2115 | 7659ca73-8890-47ae-a224-c2ab49a095fd | 1 | 2014-09-03 |
| 51672-2115-4 | EA - Each | 51672-2115 | 0a358158-1f9b-444c-a8a1-2ad54dfbc93d | 1 | 2014-09-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Acetaminophen | ACTIVE INGREDIENT | 362O9ITL9D | FEVERALL CHILDRENS (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 | |
| Acetaminophen | ACTIVE MOIETY | 362O9ITL9D | FEVERALL CHILDRENS (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 | |
| glyceryl monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | FEVERALL CHILDRENS (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 | |
| hydrogenated palm kernel oil | INACTIVE INGREDIENT | FM8D1RE2VP | FEVERALL CHILDRENS (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 | |
| PEG-100 stearate | INACTIVE INGREDIENT | YD01N1999R | FEVERALL CHILDRENS (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 | |
| polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | FEVERALL CHILDRENS (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Relief Extra Strength | ACETAMINOPHEN | Chain Drug Marketing Association | cfaf9495-e654-4dfc-ba23-d2358c3720c4 | 2024-06-13 | Warnings | 362O9ITL9D |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | CHAIN DRUG MARKETING ASSOCIATION, INC. | a6a07615-3108-436f-bbce-be7cb89ce456 | 2024-06-13 | Warnings | 362O9ITL9D |
| 8 Hour Pain Relief | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 3ec966f5-bdcb-4bd8-b265-c776ba778f25 | 2024-06-13 | Warnings | 362O9ITL9D |
| 8 Hour Arthritis Pain | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | b098ebf6-a76d-4550-b5c4-fdc3b4ceb9a8 | 2024-06-13 | Warnings | 362O9ITL9D |
| Pain Relief Extra Strength | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 1ac7ed71-5afe-d09c-e063-6294a90a3b88 | 2024-06-13 | Warnings | 362O9ITL9D |
| Pain Relief PM Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 3ce5bbf2-d449-464e-abeb-5c26866d1ab5 | 2024-06-13 | Warnings | 362O9ITL9D |
| 8HR Muscle Aches and Pain | ACETAMINOPHEN | AAA Pharmaceutical, Inc. | 15abb899-e301-40e6-e063-6294a90a4bac | 2024-06-13 | Warnings | 362O9ITL9D |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | DISCOUNT DRUG MART | 0ac12ced-70b3-7bbe-e063-6394a90aad52 | 2024-06-13 | Warnings | 362O9ITL9D |
| 8HR Muscle Aches and Pain | ACETAMINOPHEN | FSA STORE INC. | 13268603-0080-22cf-e063-6394a90a7db4 | 2024-06-13 | Warnings | 362O9ITL9D |
| topcare infants pain and fever | ACETAMINOPHEN | Topco Associates LLC | f1e940ef-3cf0-4a5c-8158-156d0e5a680d | 2024-06-13 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Trifecta Pharmaceuticals USA LLC | 026bf664-d598-73de-e063-6394a90a9206 | 2024-06-12 | Warnings | 362O9ITL9D |
| Regular Strength Pain Relief | ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 7c73fc75-af9b-177c-e053-2a91aa0ada56 | 2024-06-12 | Warnings | 362O9ITL9D |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | NuCare Pharmaceuticals,Inc. | 7d69403e-90d0-7a80-e053-2a91aa0a5552 | 2024-06-12 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | ACETAMINOPHEN AND CODEINE PHOSPHATE | NuCare Pharmaceuticals,Inc. | 6f2ce909-6356-1c2c-e053-2a91aa0a0135 | 2024-06-10 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | The Kroger Co. | fa234639-caf8-4c52-9ffe-f1c0c057ee5b | 2024-06-10 | Warnings | 362O9ITL9D |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | The Kroger Co. | bc18590d-6481-4efe-8a3b-974f7543b754 | 2024-06-10 | Warnings | 362O9ITL9D |
| pain and fever | ACETAMINOPHEN | Meijer Distribution Inc | cbfa2a25-f1e7-491e-9b67-ff2f4ba0b6cf | 2024-06-07 | Warnings | 362O9ITL9D |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | The Kroger Co. | 5691ac45-5732-412e-abb8-2bfaac59160e | 2024-06-07 | Warnings | 362O9ITL9D |
| acetaminophen for children | ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 5f86e792-3262-4ee6-e053-2991aa0a54a0 | 2024-06-06 | Warnings | 198434 362O9ITL9D |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | TARGET Corporation | 611bc1ce-460a-44a3-8e2d-b28a399d9a44 | 2024-06-06 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.